KC
AEON.WS

Kepos Capital’s AEON Biopharma Inc AEON.WS Stock Holding History

Kepos Capital’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-153,920
Closed -$14K – 353
2023
Q2 		$14K Buy
+153,920
New +$11.6K ﹤0.01% 297
2022
Q4 		$7K Hold
153,920
– – ﹤0.01% 382
2022
Q3 		$12K Hold
153,920
– – ﹤0.01% 406
2022
Q2 		$23K Hold
153,920
– – ﹤0.01% 407
2022
Q1 		$48K Hold
153,920
– – ﹤0.01% 520
2021
Q4 		$78K Buy
+153,920
New +$85.1K 0.01% 560

Other funds holding AEON.WS

AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Kepos Capital's AEON.WS Position: Q3 2023 in Review

Kepos Capital sold out of AEON Biopharma Inc (AEON.WS) in Q3 2023, closing a stake of 153,920 shares — an estimated $14K sold.

Kepos Capital first reported a position in AEON.WS in Q4 2021 and held it in 6 quarters. The position peaked at $78K in Q4 2021. 40 funds tracked by Wall St. Rank hold AEON.WS as of Q3 2023.

  • Kepos Capital reported no remaining AEON Biopharma Inc position as of Q3 2023 after selling out during the quarter.
  • Kepos Capital sold 153,920 AEON Biopharma Inc shares in Q3 2023, an estimated $14K.
  • Kepos Capital first reported a position in AEON Biopharma Inc in Q4 2021 and held it in 6 quarters.
  • Kepos Capital's AEON Biopharma Inc position peaked at $78K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q3 2023.

Based on Kepos Capital's 13F filing for Q3 2023, filed 14 Nov 2023.